NIH-funded research R01 grant

Placental Hormones and a sugar tag in Gestational Diabetes

Official title: Placental Hormones and O-GlcNAcylation in Gestational Diabetes

Funded at Medical College of Wisconsin · NIH-11377592 · Data updated 2026-11-12

A researcher is studying how placental hormones and a sugar-related modification in the placenta might contribute to gestational diabetes and its impact on mom and baby.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin
NIH-funded
Lab location1 site (Milwaukee, United States)
Project startAugust 26, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$328,354
NIH project number5R01HD104808-05
Project IDNIH-11377592 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant individuals at risk for or diagnosed with gestational diabetes and their babies may be eligible to contribute through related studies.

Less likely to help

Individuals without gestational diabetes or related placental biology questions may not directly benefit from this work.

What this research studies

This project looks at how placental hormones and a sugar-related modification called O-GlcNAcylation change with blood sugar levels during pregnancy. It aims to understand how these changes affect placental function and insulin signaling, which could influence the risk of gestational diabetes progressing to type 2 diabetes later for both mother and child. The study will use existing data and biological samples to explore the link between glucose, placental biology, and hormone secretion. If successful, the findings could guide safer, non-toxic approaches to prevent or treat GDM.

Why it matters

Potential benefit: Could lead to new, safer treatments to prevent or reduce long-term complications of gestational diabetes for mothers and their children.

How similar studies have gone: Prior work suggests placental hormones and glucose-related modifications influence placental function, with potential for new therapies, making this approach promising but still exploratory.

Where this research is happening

  • Medical College of Wisconsin
    Milwaukee, United States
    Active

Researchers

  • Principal investigator: Olivier-Van Stichelen, Stephanie — Medical College of Wisconsin
  • Study coordinator: Olivier-Van Stichelen, Stephanie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.